209 results on '"CTI Research"'
Search Results
2. BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response
3. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series
4. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
5. High-dose individualized antithymocyte globulin with therapeutic drug monitoring in high-risk cord blood transplant
6. Allergenicity assessment of new or modified protein-containing food sources and ingredients
7. m6A Reader YTHDC1 Impairs Respiratory Syncytial Virus Infection by Downregulating Membrane CX3CR1 Expression
8. CBP/P300 Inhibition Impairs CD4+ T Cell Activation: Implications for Autoimmune Disorders
9. Neuroinflammatory markers at school age in preterm born children with neurodevelopmental impairments
10. Differential dynamics of TARC during JAK-inhibitor therapy compared to biological therapies targeting type 2 inflammation
11. Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy
12. Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT
13. Thymic NK-Cells and Their Potential in Cancer Immunotherapy
14. Long-term immunity after BNT162b2 mRNA COVID-19 vaccination in pediatric patients with cancer
15. Heterozygous missense CSF1R variants hamper in vitro CD34+-derived dendritic cell generation but not in vivo dendritic cell development
16. Get Spliced: Uniting Alternative Splicing and Arthritis
17. Human Milk Oligosaccharides in Combination with Galacto- and Long-Chain Fructo-Oligosaccharides Enhance Vaccination Efficacy in a Murine Influenza Vaccination Model
18. Granulocytes and mast cells in AllergoOncology-Bridging allergy to cancer: An EAACI position paper
19. Corrigendum: Therapeutic drug monitoring of anti-thymocyte globulin in allogeneic stem cell transplantation: proof of concept (Front. Pharmacol., (2022), 13, (828094), 10.3389/fphar.2022.828094)
20. Non-Infectious Uveitis Secondary to Dupilumab Treatment in Atopic Dermatitis Patients Shows a Pro-Inflammatory Molecular Profile
21. Chemotherapy-induced intestinal epithelial damage directly promotes galectin-9-driven modulation of T cell behavior
22. Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial
23. Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML
24. Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1
25. A cis-regulatory element regulates ERAP2 expression through autoimmune disease risk SNPs
26. EAACI task force report: A consensus protocol for the basophil activation test for collaboration and external quality assurance
27. Recombinant Interleukin-1 Receptor antagonist is an effective first-line treatment strategy in new-onset systemic Juvenile Idiopathic Arthritis, irrespective of HLA-DRB1 background and IL1RN variants
28. Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy
29. N6-adenosine methylation (m6A) is involved in the life and death decisions of T cells
30. Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trial
31. Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study
32. Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis
33. Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibition
34. EAACI guidelines on the diagnosis of IgE-mediated food allergy
35. N6-Methyladenosine Directly Regulates CD40L Expression in CD4+ T Lymphocytes
36. Accidental allergic reactions to food in adolescents and adults: An overview of the factors involved and implications for prevention
37. Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer
38. Component Ana o 3 versus extract for cashew nut allergy: A diagnostic test accuracy study in adults
39. Co-sensitization between legumes is frequently seen, but variable and not always clinically relevant
40. Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity
41. Multifocal motor neuropathy is not associated with altered innate immune responses to endotoxin
42. Anti-thymocyte globulin exposure in patients with diffuse cutaneous systemic sclerosis undergoing autologous haematopoietic stem cell transplantation
43. EAACI Molecular Allergology User's Guide 2.0
44. Pyruvate metabolism controls chromatin remodeling during CD4+ T cell activation
45. Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q
46. Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort
47. The clinical and experimental treatment of Juvenile Idiopathic Arthritis
48. Inflammatory markers in cerebrospinal fluid of paediatric spinal muscular atrophy patients receiving nusinersen treatment
49. High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface disease
50. Precautionary allergen labeling: Current communication problems and potential for future improvements
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.